CD4 and COVID-19: Although, for patients with CD4+ < 350 cells/μl, additional studies are needed to evaluate the vaccine effectiveness and to determine the necessary frequency of immunization to achieve an acceptable level of protection, our current data provide health authorities with a basis for vaccination strategy of PLWH against COVID-19.